Expression of amyloid beta-protein in bone tissue of APP/PS1 transgenic mouse

National Medical Journal of China

Volumn 93, Issue 1, 2013, Pages 65-68

  Wang, Tong Hao ^a   Jiang, Yi ^a   Xiao, Lian Ping ^a  

^a TIANJIN THIRD CENTRAL HOSPITAL   (China)

Author keywords

Amyloid beta protein; Bone; Mice, transgenic; Tumour necrosis factor

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; INTERLEUKIN 6; PRESENILIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MICROARCHITECTURE; BONE TISSUE; CONTROLLED STUDY; CYTOARCHITECTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOCYTE; OSTEOPOROSIS; PATHOGENESIS; PROTEIN EXPRESSION; TIBIA; TRABECULAR BONE; TRANSGENIC MOUSE; WILD TYPE;

AMYLOID BETA-PEPTIDES; ANIMALS; BONE AND BONES; BONE DENSITY; FEMALE; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOCYTES; PRESENILIN-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874302504     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.01.020     Document Type: Article

References (14)

1. Janus C, Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol Behav, 2001, 73: 873-886.
2. 2009, 15: 632-636.
3. Tysiewicz-Dudek M, Pietraszkiewicz F, Drozdzowska B. Alzheimer's disease and osteoporosis: common risk factors or one condition predisposing to the other? Ortop Traumatol Rehabil, 2008, 10: 315-323.
4. Yang M W, Wang T H, Chu L W, et al. Curcumin improves bone microbarchitecture and enhances mineral density in APP/PS1 transgenic mice. J Phytomedicine, 2011, 18: 205-213.
5. Liu L, Ikonen S. Effects of fimbria-fornix lesion and amyloid pathology on spatial learning and memory in transgenic APP + PS1 mice. Behav Brain Res, 2002, 134: 433-445.
6. Jankowsky J L, Fadale D J, Anderson J, et al. Mutant presenilins specifically elevate the levels of Aβ42 residue β-amyloid peptide in vivo: evidence for augmentation of Aβ42-specific-y secretase. Human Mol Genet, 2004, 13: 159-170.
7. Carmela R. Abnormal reactive astrocytes and antichymotrypsin in Alzheimer's disease. Neurobiol Aging, 2001, 22: 931-936.
8. Chong Y H, Sung J H, Shin S A, et al. Effectsof the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor proteinon the production of the tumor necrosis factor-alpha and matrix metallop-roteinase-9 by human monocyticTHP-1. Biol Chem, 2001, 27: 23511-23517.
9. Tan J, Town T, Mori T, et al. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J Neurosci, 2000, 20: 7587-7594.
10. Sutton E T, Thomas T, Bryant M W, et al. Amyloid-β peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1. J Submicrosc Cytol Pathol, 1999, 31: 313-323.
11. Kimble R B, Srivastava S, Ross P F, et al. Estrogen deficiency increases the ability of stromal cell to supportmurine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-α mediated stimulation of macropage colony stimulating factor production. J Biol Chem, 1996, 271: 28890-28897.
12. Li W P, Chan W Y, Lai H W, et al. Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer's patients. J Mol Neurosci, 1997, 8: 75-82.
13. Ohyagi Y, Asahara H, Chui D H, et al. Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J, 2005, 19: 255-257.
14. Magrané J, Rosen K M, Smith R C, et al. Intraneuronal β-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J Neurosci, 2005, 25: 10960-10969.